Determinants of bone microarchitecture and mechanical properties in obese men

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 11, 2012, Pages 4115-4122

  Bredella, Miriam A ^a   Lin, Eleanor ^a   Gerweck, Anu V ^a   Landa, Melissa G ^a   Thomas, Bijoy J ^a   Torriani, Martin ^a   Bouxsein, Mary L ^a   Miller, Karen K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ESTRADIOL; GROWTH HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ARTICLE; BIOMECHANICS; BODY COMPOSITION; BODY MASS; BONE MARROW; BONE STRUCTURE; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; ESTRADIOL BLOOD LEVEL; FINITE ELEMENT ANALYSIS; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; INTRAABDOMINAL FAT; MALE; MUSCULOSKELETAL SYSTEM PARAMETERS; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RADIUS; TESTOSTERONE BLOOD LEVEL; THIGH; THREE DIMENSIONAL IMAGING;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BODY COMPOSITION; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; CROSS-SECTIONAL STUDIES; ESTRADIOL; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OBESITY; TESTOSTERONE; VITAMIN D;

EID: 84868611726     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2246     Document Type: Article

References (40)

1. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M 2011 Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378:815-825
2. Wyatt HR 2003 The prevalence of obesity. Prim Care 30:267-279 (Pubitemid 36791417)
3. Cole ZA, Dennison EM, Cooper C 2008 Osteoporosis epidemiology update. Curr Rheumatol Rep 10:92-96
4. Dawson-Hughes B, Looker AC, Tosteson AN, Johansson H, Kanis JA, Melton 3rd LJ 2012 The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008. Osteoporos Int 23:811-820
5. Albala C, Yáñez M, Devoto E, Sostin C, Zeballos L, Santos JL 1996 Obesity as a protective factor for postmenopausal osteoporosis. Int J Obes Relat Metab Disord 20:1027-1032 (Pubitemid 26366457)
6. Klein KO, Larmore KA, de Lancey E, Brown JM, Considine RV, Hassink SG 1998 Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab 83:3469-3475 (Pubitemid 28500873)
7. Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, Harrington LM, Breggia A, Rosen CJ, Miller KK 2011 Determinants of bone mineral density in obese premenopausal women. Bone 48:748-754
8. Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, Rosen CJ, Klibanski A, Miller KK 2011 Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring) 19:49-53
9. Di Iorgi N, Mittelman SD, Gilsanz V 2008 Differential effect of marrow adiposity and visceral and subcutaneous fat on cardiovascular risk in young, healthy adults. Int J Obes (Lond) 32:1854-1860
10. Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD 2009 Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 94:3387-3393
11. Russell M, Mendes N, Miller KK, Rosen CJ, Lee H, Klibanski A, Misra M 2010 Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab 95:1247-1255
12. Nielson CM, Marshall LM, Adams AL, LeBlanc ES, Cawthon PM, Ensrud K, Stefanick ML, Barrett-Connor E, Orwoll ES 2011 BMI and fracture risk in older men: the Osteoporotic Fractures in Men Study (MrOS). J Bone Miner Res 26:496-502
13. Kanis JA, Bianchi G, Bilezikian JP, Kaufman JM, Khosla S, Orwoll E, Seeman E 2011 Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int 22:2789-2798
14. Miller KK, Biller BM, Lipman JG, Bradwin G, Rifai N, Klibanski A 2005 Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab 90:768-774 (Pubitemid 40279194)
15. Pasquali R 2006 Obesity and androgens: facts and perspectives. Fertil Steril 85:1319-1340
16. Mora S, Pitukcheewanont P, Nelson JC, Gilsanz V 1999 Serum levels of insulin-like growth factor I and the density, volume, and cross-sectional area of cortical bone in children. J Clin Endocrinol Metab 84:2780-2783 (Pubitemid 30642012)
17. Kassem M, Mosekilde L, Eriksen EF 1994 Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro. Growth Regul 4:131-135 (Pubitemid 24315352)
18. Ohlsson C, Mellström D, Carlzon D, Orwoll E, Ljunggren O, Karlsson MK, Vandenput L 2011 Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study. J Bone Miner Res 26:865-872
19. Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A 1996 Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 125:883-890
20. Glass AR 1989 Endocrine aspects of obesity. Med Clin North Am 73:139-160 (Pubitemid 19032519)
21. Martini LA, Wood RJ 2006 Vitamin D status and the metabolic syndrome. Nutr Rev 64:479-486 (Pubitemid 44808263)
22. Rajakumar K, de las Heras J, Chen TC, Lee S, Holick MF, Arslanian SA 2011 Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab 96:1560-1567
23. Boutroy S, Bouxsein ML, Munoz F, Delmas PD 2005 In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 90:6508-6515 (Pubitemid 41759306)
24. Boutroy S, Van Rietbergen B, Sornay-Rendu E, Munoz F, Bouxsein ML, Delmas PD 2008 Finite element analysis based on in vivo HRpQCT images of the distal radius is associated with wrist fracture in postmenopausal women. J Bone Miner Res 23:392-399 (Pubitemid 351304669)
25. Schellinger D, Lin CS, Hatipoglu HG, Fertikh D 2001 Potential value of vertebral proton MR spectroscopy in determining bone weakness. AJNR Am J Neuroradiol 22:1620-1627 (Pubitemid 32862282)
26. Han TS, van Leer EM, Seidell JC, Lean ME 1995 Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311:1401-1405
27. van Rietbergen B, Weinans H, Huiskes R, Odgaard A 1995 A new method to determine trabecular bone elastic properties and loading using micromechanical finite-element models. J Biomech 28:69-81 (Pubitemid 24343733)
28. Bredella MA, Fazeli PK, Miller KK, Misra M, Torriani M, Thomas BJ, Ghomi RH, Rosen CJ, Klibanski A 2009 Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 94:2129-2136
29. Sornay-Rendu E, Boutroy S, Munoz F, DelmasPD 2007 Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study. J Bone Miner Res 22:425-433 (Pubitemid 46797126)
30. Cartier A, Lemieux I, Alméras N, Tremblay A, Bergeron J, Després JP 2008 Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-α in men. J Clin Endocrinol Metab 93:1931-1938 (Pubitemid 351656540)
31. Giustina A, Mazziotti G, Canalis E 2008 Growth hormone, insulinlike growth factors, and the skeleton. Endocr Rev 29:535-559
32. Rosén T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA 1997 Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137:240-245 (Pubitemid 27405107)
33. Yakar S, Canalis E, Sun H, Mejia W, Kawashima Y, Nasser P, Courtland HW, Williams V, Bouxsein M, Rosen C, Jepsen KJ 2009 Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions. J Bone Miner Res 24:1481-1492
34. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL,WuY, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D 2002 Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781
35. Zumoff B, Strain GW, Miller LK, Rosner W, Senie R, Seres DS, Rosenfeld RS 1990 Plasma free and non-sex-hormone-binding-globulin- bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab 71:929-931
36. Bouillon R, Bex M, Vanderschueren D, Boonen S 2004 Estrogens are essential for male pubertal periosteal bone expansion. J Clin Endocrinol Metab 89:6025-6029 (Pubitemid 39628410)
37. Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F, Duboeuf F, Delmas PD 2001 Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab 86:192-199
38. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C 2004 Androgens and bone. Endocr Rev 25:389-425 (Pubitemid 38786452)
39. Kristinsson JO, Valdimarsson O, Sigurdsson G, Franzson L, Olafsson I, Steingrimsdottir L 1998 Serum 25-hydroxyvitamin D levels and bone mineral density in 16-20 years-old girls: lack of association. J Intern Med 243:381-388 (Pubitemid 28255483)
40. Rosen CJ, Bouxsein ML 2006 Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2:35-43 (Pubitemid 43153647)